Locations
Baltimore, MD, USA · United States · North America · Baltimore, MD, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health
Size
51-200 employees
Stage
Series C+
founded in
2010
Personal Genome Diagnostics (PGDx) is dedicated to advancing precision oncology by providing comprehensive genomic profiling solutions and services. Their innovative products, such as the PGDx elio series, enable rapid and reliable genomic insights for cancer patients, facilitating personalized treatment decisions. PGDx differentiates itself through its proprietary bioinformatics and kitted solutions that democratize access to genomic testing. With a strong market position backed by partnerships and a focus on removing barriers to testing, PGDx is well-positioned to impact cancer care significantly. The company has seen traction through its FDA-cleared tests and collaborations with biopharma companies, enhancing its role in oncology drug development.
Something looks off?On-site & Remote